Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Flatt

Showing results (91-100 of 325) with videos related to

Pageof 33
Sort By:
Bone|July 16, 2013
Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and qualityAleksandra Mieczkowska, Nigel Irwin, Peter R Flatt, et al.
Pflugers Archiv : European Journal of Physiology|January 7, 2015
Pseudoislet formation enhances gene expression, insulin secretion and cytoprotective mechanisms of clonal human insulin-secreting 1.1B4 cellsAlastair D Green, Srividya Vasu, Neville H McClenaghan, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic miceVadivel Parthsarathy, Christopher Hogg, Peter R Flatt, et al.
Peptides|May 6, 2014
Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agentsJ Michael Conlon, Milena Mechkarska, Miodrag L Lukic, et al.
Biochemical Pharmacology|May 6, 2008
C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetesVictor A Gault, Barry D Kerr, Nigel Irwin, et al.
Biochemical Pharmacology|October 23, 2012
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob miceNigel Irwin, Ian A Montgomery, R Charlotte Moffett, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2024
Strategy for the Identification of Host-Defense Peptides in Frog Skin Secretions with Therapeutic Potential as Antidiabetic AgentsJ Michael Conlon, R Charlotte Moffett, Peter R Flatt, et al.
The Journal of Endocrinology|January 8, 2011
Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed miceVictor A Gault, David W Porter, Nigel Irwin, et al.
Biochimica Et Biophysica Acta|April 16, 2013
(pGlu-Gln)-CCK-8[mPEG]: a novel, long-acting, mini-PEGylated cholecystokinin (CCK) agonist that improves metabolic status in dietary-induced diabetesNigel Irwin, Pamela Frizelle, Finbarr P M O'Harte, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2018
Identification of Components in Frog Skin Secretions with Therapeutic Potential as Antidiabetic AgentsJ Michael Conlon, R Charlotte Moffett, Jérôme Leprince, et al.
Pageof 33

Showing results (91-100 of 325) with videos related to

Sort By:
Pageof 33
Bone|July 16, 2013
Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and qualityAleksandra Mieczkowska, Nigel Irwin, Peter R Flatt, et al.
Pflugers Archiv : European Journal of Physiology|January 7, 2015
Pseudoislet formation enhances gene expression, insulin secretion and cytoprotective mechanisms of clonal human insulin-secreting 1.1B4 cellsAlastair D Green, Srividya Vasu, Neville H McClenaghan, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic miceVadivel Parthsarathy, Christopher Hogg, Peter R Flatt, et al.
Peptides|May 6, 2014
Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agentsJ Michael Conlon, Milena Mechkarska, Miodrag L Lukic, et al.
Biochemical Pharmacology|May 6, 2008
C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetesVictor A Gault, Barry D Kerr, Nigel Irwin, et al.
Biochemical Pharmacology|October 23, 2012
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob miceNigel Irwin, Ian A Montgomery, R Charlotte Moffett, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2024
Strategy for the Identification of Host-Defense Peptides in Frog Skin Secretions with Therapeutic Potential as Antidiabetic AgentsJ Michael Conlon, R Charlotte Moffett, Peter R Flatt, et al.
The Journal of Endocrinology|January 8, 2011
Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed miceVictor A Gault, David W Porter, Nigel Irwin, et al.
Biochimica Et Biophysica Acta|April 16, 2013
(pGlu-Gln)-CCK-8[mPEG]: a novel, long-acting, mini-PEGylated cholecystokinin (CCK) agonist that improves metabolic status in dietary-induced diabetesNigel Irwin, Pamela Frizelle, Finbarr P M O'Harte, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2018
Identification of Components in Frog Skin Secretions with Therapeutic Potential as Antidiabetic AgentsJ Michael Conlon, R Charlotte Moffett, Jérôme Leprince, et al.
Pageof 33